Zhejiang Ausun Pharmaceutical Co Ltd
603229
Company Profile
Business description
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Contact
No.5, Donghai 4th Avenue
chemical raw materials base Linhai Park East
Zhejiang Province
Taizhou317016
CHNT: +86 57685589367
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,328
Stocks News & Analysis
stocks
ASX share undervalued as margins expected to rebound
This ASX share remains overlooked despite a strong outlook.
stocks
Cheap retail REIT with an attractive yield
Lower consumer spending unlikely to buckle this retail REIT.
stocks
Expanding store network for ASX listed retailer
Sales growth but lack of margin expansion due to competition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,178.40 | 62.70 | 0.69% |
| CAC 40 | 8,447.27 | 63.26 | 0.75% |
| DAX 40 | 24,910.41 | 16.40 | 0.07% |
| Dow JONES (US) | 51,999.67 | 328.64 | 0.64% |
| FTSE 100 | 10,494.21 | 63.59 | 0.61% |
| HKSE | 24,403.96 | 89.99 | -0.37% |
| NASDAQ | 26,376.34 | 307.60 | -1.15% |
| Nikkei 225 | 70,066.34 | 661.84 | 0.95% |
| NZX 50 Index | 13,394.62 | 31.51 | -0.23% |
| S&P 500 | 7,511.35 | 42.94 | -0.57% |
| S&P/ASX 200 | 8,960.30 | 59.50 | 0.67% |
| SSE Composite Index | 4,084.54 | 7.35 | -0.18% |